新型コロナウイルス感染症に関する損失、その他、売上原価他2件
- 【期間】
| 年度 | 新型コロナウイルス感染症に関する損失 | その他 | 売上原価 | 段階取得に係る差損 | 株主資本合計 |
|---|
| 2007/03 | - | | - | | - | | - | | 0.25兆 | |
| 2008/03 | - | | 326億 | | 1.67兆 | | - | | 0.28兆 | +11.7% |
| 2009/03 | - | | 279億 | -14.6% | 1.27兆 | -23.7% | - | | 0.24兆 | -14.6% |
| 2010/03 | - | | 202億 | -27.4% | 0.96兆 | -24.3% | - | | 0.24兆 | +3.5% |
| 2011/03 | - | | 232億 | +14.6% | 1.21兆 | +26.2% | - | | 0.29兆 | +17.7% |
| 2012/03 | - | | 247億 | +6.5% | 1.19兆 | -2.1% | - | | 0.37兆 | +29% |
| 2013/03 | - | | 246億 | -0.5% | 1.4兆 | +17.8% | - | | 0.45兆 | +22.8% |
| 2014/03 | - | | 283億 | +15.2% | 1.44兆 | +2.9% | 11.6億 | | 0.55兆 | +21.8% |
| 2015/03 | - | | 422億 | +49.2% | 1.54兆 | +7.1% | - | | 0.61兆 | +10% |
| 2016/03 | - | | 494億 | +16.9% | 1.57兆 | +2% | - | | 0.65兆 | +6.3% |
| 2017/03 | - | | 528億 | +6.9% | 1.62兆 | +3.1% | - | | 0.72兆 | +10.6% |
| 2018/03 | - | | 589億 | +11.7% | 1.7兆 | +4.7% | - | | 0.8兆 | +11.2% |
| 2019/03 | - | | 600億 | +1.9% | 1.77兆 | +3.8% | - | | 0.8兆 | +1% |
| 2020/03 | - | | 716億 | +19.3% | 1.73兆 | -2% | - | | 0.86兆 | +6.6% |
| 2021/03 | 33億 | | 678億 | -5.4% | 1.61兆 | -7.2% | - | | 0.88兆 | +2.5% |
| 2022/03 | 1.04億 | -96.8% | 965億 | +42.3% | 2.06兆 | +28.1% | - | | 1.01兆 | +14.7% |
| 2023/03 | - | | 1091億 | +13.1% | 2.6兆 | +26.5% | - | | 1.1兆 | +9.2% |
| 2024/03 | - | | 1039億 | -4.8% | 2.71兆 | +4.1% | - | | 1.16兆 | +5.6% |
